Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Oncol.

Sec. Gynecological Oncology

This article is part of the Research TopicEvolving Therapies in Gynecological Oncology: From Chemotherapy to Personalized MedicineView all 15 articles

Uterine Tumors Resembling Ovarian Sex Cord Tumors: Rare Case Report and Literature Review

Provisionally accepted
Kaige  PeiKaige Pei1Xiumei  XuXiumei Xu1Yonghong  LiYonghong Li2Yuhao  LongYuhao Long3Mingrong  XiMingrong Xi1Ruiqi  DuanRuiqi Duan1*
  • 1West China Second University Hospital, Sichuan University, Chengdu, China
  • 2The People's Hospital of Wenjiang Chengdu, Chengdu, China
  • 3Department of Obstetrics and Gynecology, Meishan Women and Children's Hospital,Alliance Hospital of West China Second University Hospital,Sichuan University, Meishan, China

The final, formatted version of the article will be published soon.

Uterine tumors resembling ovarian sex-cord tumors (UTROSCT) are rare mesenchymal neoplasms with low malignant potential and polyphenotypic immunoprofiles. A 38-year-old nullipara presented with menorrhagia; trans-vaginal ultrasound revealed a 26-mm, richly vascular submucosal mass. Complete hysteroscopic excision was achieved without residual disease. Microscopy showed anastomosing cords, hollow tubules and bland spindled cells (0-1 mitosis/10 HPF). Immunohistochemistry demonstrated diffuse AE1/3, CD56, WT-1 and synaptophysin positivity, while inhibin-α, calretinin and ER/PR were negative; desmin highlighted entrapped myometrium. Ki-67 index was ~5%. Break-apart FISH and next-generation sequencing (141-gene solid-tumor panel) disclosed no pathogenic fusions involving ESR1, GREB1, NCOA2/3 or NR4A3, nor mutations in TP53, BRCA1/2 or mismatch-repair genes, consistent with the fusion-negative UTROSCT subset (~30–45% of cases). At 20 months the patient is disease-free with regular menses and intact fertility. We review diagnostic clues, differential diagnoses, molecular taxonomy and fertility-sparing strategies, underscoring the value of comprehensive genomic profiling for accurate classification and prognostication of this uncommon uterine tumor.

Keywords: Fertility-sparing surgery, literature review, Molecular classification, rare case report, UTROSCT

Received: 02 Jan 2026; Accepted: 30 Jan 2026.

Copyright: © 2026 Pei, Xu, Li, Long, Xi and Duan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ruiqi Duan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.